BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12640493)

  • 21. First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.
    Rave K; Sidharta PN; Dingemanse J; Heinemann L; Roggen K
    Diabetes Technol Ther; 2010 Feb; 12(2):117-23. PubMed ID: 20105041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
    Pisu E; Lombardi A; De Benedictis D; Bozzo C; Chiara E; Baggiore C; Bruno A; Cravero L; Pagano G; Lenti G
    Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
    Vauhkonen I; Niskanen L; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    J Clin Invest; 1998 Jan; 101(1):86-96. PubMed ID: 9421470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families.
    Humphriss DB; Stewart MW; Berrish TS; Barriocanal LA; Trajano LR; Ashworth LA; Brown MD; Miller M; Avery PJ; Alberti KG; Walker M
    Diabetologia; 1997 Oct; 40(10):1185-90. PubMed ID: 9349600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.
    Pratipanawatr W; Pratipanawatr T; Cusi K; Berria R; Adams JM; Jenkinson CP; Maezono K; DeFronzo RA; Mandarino LJ
    Diabetes; 2001 Nov; 50(11):2572-8. PubMed ID: 11679436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband.
    Tripathy D; Lindholm E; Isomaa B; Saloranta C; Tuomi T; Groop L
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1297-303. PubMed ID: 12954593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients.
    Pigon J; Giacca A; Ostenson CG; Lam L; Vranic M; Efendic S
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3702-8. PubMed ID: 8855826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of impaired insulin secretion and insulin resistance in normoglycemic male subjects with family history of type 2 diabetes.
    Ryder E; Gómez ME; Fernández V; Campos G; Morales LM; Valbuena H; Raleigh X
    Diabetes Res Clin Pract; 2003 May; 60(2):95-103. PubMed ID: 12706317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
    Tripathy D; Merovci A; Basu R; Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2842-2850. PubMed ID: 30789980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Metabolic Disorders and Impaired Insulin Secretory Function in the First-Degree Relatives of Type 2 Diabetic Patients with Normal Glucose Tolerance.
    Deng L; Liu S; Gong Y; Tian H; Liu Y; Song J; Ran X; Yu H; Zhang X; Long Y; Ren Y
    Metab Syndr Relat Disord; 2016 Nov; 14(9):431-436. PubMed ID: 27689409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.
    Eriksson J; Franssila-Kallunki A; Ekstrand A; Saloranta C; Widén E; Schalin C; Groop L
    N Engl J Med; 1989 Aug; 321(6):337-43. PubMed ID: 2664520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower beta-cell secretion in physically active first-degree relatives of type 2 diabetes patients.
    Zonderland ML; Dubbeldam S; Erkelens DW; van Haeften TW
    Metabolism; 2000 Jul; 49(7):833-8. PubMed ID: 10909991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery.
    Kautzky-Willer A; Pacini G; Niederle B; Schernthaner G; Prager R
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):147-55. PubMed ID: 1395065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.
    Pimenta W; Korytkowski M; Mitrakou A; Jenssen T; Yki-Jarvinen H; Evron W; Dailey G; Gerich J
    JAMA; 1995 Jun; 273(23):1855-61. PubMed ID: 7776502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes of leptin, tumor necrosis factor-alpha, neuropeptide Y levels and their association with insulin resistance and insulin secretion function in normal glucose tolerant first-degree relatives of familial type 2 diabetic pedigrees].
    Ren Y; Li X; Tian H; Liang J; Zhang X; Yu H; Wang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1341-5. PubMed ID: 21374991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.